Myriad Genetics Inc (MYGN)
Operating profit margin
| Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | -155,900 | -233,100 | -257,400 | -278,200 | -263,100 | -167,200 | -140,600 | -131,500 | -166,400 | -169,400 | -190,500 | -187,000 | -175,400 | -288,300 | -250,400 | -231,700 | -169,000 | -29,400 | -14,500 | 7,600 |
| Revenue (ttm) | US$ in thousands | 794,900 | 766,400 | 745,400 | 731,500 | 696,200 | 691,900 | 675,200 | 820,600 | 831,200 | 839,900 | 846,300 | 666,200 | 590,100 | 564,400 | 586,600 | 627,900 | 750,000 | 801,700 | 822,500 | 840,100 |
| Operating profit margin | -19.61% | -30.41% | -34.53% | -38.03% | -37.79% | -24.17% | -20.82% | -16.02% | -20.02% | -20.17% | -22.51% | -28.07% | -29.72% | -51.08% | -42.69% | -36.90% | -22.53% | -3.67% | -1.76% | 0.90% |
June 30, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-155,900K ÷ $794,900K
= -19.61%
Myriad Genetics Inc has experienced fluctuating operating profit margins over the past several quarters. The operating profit margin, which indicates the company's efficiency in generating profits from its core operations, has shown a downward trend from December 2019 to June 2024.
The operating profit margin was notably negative in the recent quarters, with values ranging from -19.61% to -38.03%. This indicates that the company's operating expenses and costs of goods sold have been relatively high compared to its revenues during these periods.
The most recent operating profit margin of -19.61% for June 30, 2024, shows a slight improvement compared to the previous quarter. However, it is important to note that the negative margin still suggests that the company is facing challenges in controlling its operational costs and maximizing profitability.
Overall, the analysis of Myriad Genetics Inc's operating profit margin highlights the need for the company to enhance its operational efficiency and cost management strategies to improve profitability and financial performance in the future.
Peer comparison
Jun 30, 2024